XT
HQL

XTX Topco’s abrdn Life Sciences Investors HQL Stock Holding History

XTX Topco’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Buy
+23,234
New +$411K 0.01% 2530

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

XTX Topco's HQL Position: Q2 2026 in Review

XTX Topco opened a new position in abrdn Life Sciences Investors (HQL) in Q2 2026: 23,234 shares worth $465K. The stake represents 0.01% of the portfolio and ranks #2530 among its holdings.

83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • XTX Topco held 23,234 shares of abrdn Life Sciences Investors worth $465K as of Q2 2026.
  • abrdn Life Sciences Investors was a new XTX Topco position in Q2 2026.
  • abrdn Life Sciences Investors made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2530 holding.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.